<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02493140</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00160-49</org_study_id>
    <nct_id>NCT02493140</nct_id>
  </id_info>
  <brief_title>Evaluation of Efficacy of a Cashew Apple Extract on Weight Management and Associated Metabolic Risk Factors in Overweight/Obese Volunteers</brief_title>
  <official_title>Evaluation of Efficacy and Safety of a Cashew Apple Extract on Weight Management and Associated Metabolic Risk Factors in Overweight/Obese Volunteers: a Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dialpha</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Naturalpha</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Dialpha</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy and safety of a cashew apple extract on
      weight management and associated metabolic risk factors in overweight/obese volunteers,
      versus placebo, after 12 weeks of treatment.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body weight reduction</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body weight variation</measure>
    <time_frame>6 weeks and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat variation</measure>
    <time_frame>6 and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI variation</measure>
    <time_frame>6 and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist and hip circumferences variation</measure>
    <time_frame>6 and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting glycemia variation</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting insulinemia variation</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HOMA-IR index variation</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of glycemia 2h post glucose solution intake</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipids (total cholesterol, HDL, LDL, triglycérides) variation</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRPus variation</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic and diastolic blood pressure variation</measure>
    <time_frame>6 and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (blood parameters measurements: urea, creatinine, ASAT, ALAT) with adverse events recording</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Weight Loss</condition>
  <arm_group>
    <arm_group_label>Cashew apple extract (Cashewin)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cashew apple extract (Cashewin)</intervention_name>
    <description>6 capsules per day (2 capsules 3 times per day, to be taken before breakfast, lunch and diner, each capsule containing 200 mg of Cashewin) during 12 weeks</description>
    <arm_group_label>Cashew apple extract (Cashewin)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>6 capsules per day (2 capsules 3 times per day, to be taken before breakfast, lunch and diner) during 12 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  27 ≤ BMI ≤ 35 kg/m²

          -  Abdominal obesity

          -  Acceptance to adhere to diet and physical activity recommendations while maintaining
             global lifestyle habits

          -  Stable body weight (&lt;5% variation) within the last 3 months prior to screening

        Exclusion Criteria:

          -  Allergy to nuts and products thereof and allergy to mango fruit

          -  Type I or II diabetes

          -  Smokers

          -  Severe chronic diseases

          -  History of bariatric surgery and eating disorders

          -  Use of weight management products or medications which could affect nutrients
             absorption, lipids or carbohydrates metabolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Deplanque</last_name>
    <role>Principal Investigator</role>
    <affiliation>Naturalpha</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marie Peytavy-Izard</last_name>
    <phone>+33467404419</phone>
    <email>m.peytavy@dialpha.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Nutrition Center Naturalpha (CNCN)</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CNCN</last_name>
      <phone>+33(0)320877575</phone>
      <email>cncn@naturalpha.com</email>
    </contact>
    <investigator>
      <last_name>Xavier Deplanque</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/07/WC500170278.pdf</url>
    <description>Guideline on clinical evaluation of medicinal products used in weight control (draft)</description>
  </link>
  <link>
    <url>http://www.nhlbi.nih.gov/files/docs/guidelines/prctgd_c.pdf</url>
    <description>Identification, Evaluation and Treatment of Overweight and Obesity in Adults</description>
  </link>
  <link>
    <url>http://www.nhlbi.nih.gov/files/docs/guidelines/ob_gdlns.pdf</url>
    <description>Clinical guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in adults</description>
  </link>
  <reference>
    <citation>Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004 Mar;79(3):379-84.</citation>
    <PMID>14985210</PMID>
  </reference>
  <reference>
    <citation>Ribeiro da Silva LM, Teixeira de Figueiredo EA, Silva Ricardo NM, Pinto Vieira IG, Wilane de Figueiredo R, Brasil IM, Gomes CL. Quantification of bioactive compounds in pulps and by-products of tropical fruits from Brazil. Food Chem. 2014 Jan 15;143:398-404. doi: 10.1016/j.foodchem.2013.08.001. Epub 2013 Aug 9.</citation>
    <PMID>24054258</PMID>
  </reference>
  <reference>
    <citation>Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr. 2000 Nov;72(5):1074-81.</citation>
    <PMID>11063431</PMID>
  </reference>
  <reference>
    <citation>P. Suganya and R. Dharshini. Value added products from cashew apple - an alternate nutritional source. International Journal of current research, Vol. 3, Issue 7, pp. 177-180, July 2011</citation>
  </reference>
  <reference>
    <citation>Prasertsri P, Roengrit T, Kanpetta Y, Tong-Un T, Muchimapura S, Wattanathorn J, Leelayuwat N. Cashew apple juice supplementation enhanced fat utilization during high-intensity exercise in trained and untrained men. J Int Soc Sports Nutr. 2013 Mar 7;10(1):13. doi: 10.1186/1550-2783-10-13.</citation>
    <PMID>23497120</PMID>
  </reference>
  <reference>
    <citation>Vergara CMAC, Honorato TL, Maia GA, Rodrigues S. Prebiotic effect of fermented cashew apple (Anacardium occidentale L) juice. LWT-Food Sci Technol. 2010; 43:141-145.</citation>
  </reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2015</study_first_submitted>
  <study_first_submitted_qc>July 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2015</study_first_posted>
  <last_update_submitted>July 8, 2015</last_update_submitted>
  <last_update_submitted_qc>July 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Weight management</keyword>
  <keyword>cashew apple extract</keyword>
  <keyword>overweight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

